Literature DB >> 10767489

Detection of CFTR gene mutations in patients suffering from chronic bronchitis.

M Kostuch1, A Semczuk, W Szarewicz-Adamczyk, U Gasowska-Giszczak, J Wojcierowski, L Kulczycki.   

Abstract

BACKGROUND: The purpose of the study was to examine cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in patients suffering from chronic bronchitis.
METHODS: Thirty-two patients admitted to the Department of Pulmonology, Lublin School of Medicine, Lublin, Poland between 1995 and 1996 due to chronic bronchitis were included in the study. Patients were analyzed for the eight most common mutations of the CFTR gene (DeltaF508, G542X, N1303K, 1717-1(GoA)), W1282X, G551D, R553X, and DeltaI507 by the reverse-hybridization method.
RESULTS: CFTR gene mutations were found in five of 32 (16%) patients, all within the DeltaF508 region of the CFTR gene. All positive samples were obtained from patients heterozygous for the DeltaF508 mutation. The presence of the DeltaF508 mutation was considered statistically significant when our study group was compared to the study of Poland's general population (p <0.05 Fisher's exact test).
CONCLUSION: Our results suggest there is an increased presence of the DeltaF508 point mutation of the CFTR gene in Polish patients suffering from chronic bronchitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767489     DOI: 10.1016/s0188-4409(99)00065-x

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  2 in total

1.  Analysis of most common CFTR mutations in patients affected by nasal polyps.

Authors:  Marzena Kostuch; Janusz Klatka; Andrzej Semczuk; Jacek Wojcierowski; Lucas Kulczycki; Jan Oleszczuk
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-06-17       Impact factor: 2.503

2.  Impact of heterozygote CFTR mutations in COPD patients with chronic bronchitis.

Authors:  S Vamsee Raju; Jody H Tate; Sandra K G Peacock; Ping Fang; Robert A Oster; Mark T Dransfield; Steven M Rowe
Journal:  Respir Res       Date:  2014-02-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.